CROI 2014

Anita Kohli, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.Anita Kohli, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Interferon-free regimens

Six-week oral hep C treatment cures hard-to-treat patients.

Prof. Rajendar Reddy, of the University of Pennsylvania Hospital, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.Prof. Rajendar Reddy, of the University of Pennsylvania Hospital, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Interferon-free regimens

AbbVie '3D' combination cures 99% of genotype 1b hep C.

Prof. Douglas Dieterich of Mount Sinai School of Medicine discusses recent advances in treatment of hepatitis C and HIV co-infection at CROI 2014. Photo by Liz Highleyman / hivandhepatitis.comProf. Douglas Dieterich of Mount Sinai School of Medicine discusses recent advances in treatment of hepatitis C and HIV co-infection at CROI 2014. Photo by Liz Highleyman / hivandhepatitis.com

HIV and HCV co-infection

Simeprevir cures almost 80% of first-time patients.

infohep news